To the editor: Primary myelofibrosis is a myeloproliferative disease, and results of conventional treatment remain unsatisfactory.[1][1],[2][2] Allogeneic stem cell transplantation after dose-reduced conditioning has become a reasonable, curative treatment option.[3][3],[4][4] Single case reports
No takes yet. Share an insight, caveat, or question.
Kröger et al. (2009) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: